Stroke trials in Oman
1 trial · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2RecruitingTrial-stage medicine
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
- Where
- Muscat
- Age
- 12 years to 16 years
- People
- 27 worldwide
- Run by
- Forma Therapeutics, Inc.
See details and how to joinNCT05953584Registry updated 2026-09-10
This page is not medical advice. Talk to your doctor before contacting a trial.